Exam 2 Active Transport Flashcards

1
Q

Two important characteristics of transporters

A
  1. Traffic drugs in/out of cells

2. Important drug targets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Movement of nonpolar stuff down the electrochemical gradient that involves desolvation and has a high activation barrier

A

Simple diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Protein assisted movement down electrochemical gradient

A

Facilitated diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Protein assisted, energy requiring transport against electrochemical gradient that is often coupled with ATP hydrolysis

A

Active transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Type of protein that are very specific for ions and substrate molecules. Catalyzation rates are well below diffusion, and they also display saturation kinetics

A

Transporters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Type of protein that shows moderate specificity for ions, and are not saturable with an ion substrate. They allow a much faster rate of diffusion than protein transporters

A

Channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is ion movement dictated by in protein channels?

A

Electochemical gradient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do transporters rely on to determine specificity of correct ions?

A

Size and electrostatic criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Both ions move through the membrane in the same direction from a low concentration to a high concentration

A

Symport (secondary active)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

One ion moves from high to low concentration in one direction, while another ion moves from low to high concentration in the other direction

A

Antiport (secondary active)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ATP is used to move an ion from low to high concentration

A

Primary active transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A protein transporter moves an ion from high to low concentration without ATP use

A

Facilitated diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Measure of transmembrane electrogradients

A

Vm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vm > 0

A

High charge differentials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vm < 0

A

Low charge differentials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does the spontaneous movement of ions depend on? (2)

A
  1. Difference in solute concentration

2. Vm

17
Q

What is the benefit of using a protein carrier when moving a polar molecule across the membrane?

A

A hydration shell is usually formed around a polar molecule. This shell has to be removed when it passively diffuses through the lipid portion of the membrane; however, when a transporter is used, the hydration layer is removed easier and saves free energy expenditure

18
Q

How many more times efficient is glucose transport by a transporter, than by diffusion?

A

50,000 times

19
Q

A simple glucose uptake uniporter

A

GLUT 1

20
Q

An insulin-responsive glucose transporter

A

GLUT 4

21
Q

A glucose transporter that responds to large intracellular glucose due to glycogenolysis and can transport it out of the cell (puts glucose into the blood stream)

A

GLUT 2

22
Q

Pathology of Type II Diabetes

A

Insulin binding causing endosomes harboring GLUT 4 to fuse with cell membrane, that results in an increased glucose uptake into the cell. Deficiencies in this signaling pathway cause GLUT 4 to be trapped in endosomes and prevents fusion to the membrane (GLUT 4 transporter isn’t brought back to surface of cell)

23
Q

What are two characteristics of active transport

A
  1. Some source of energy

2. Movement of a solute against its gradient

24
Q

Movement of a solute against it’s gradient, coupled with ATP hydrolysis

A

Primary active transport

25
Q

Movement of one solute against its gradient and one solvent down its gradient, where the movement of solute down the gradient supplies energy for this process

A

Secondary active transport

26
Q

Class of ATPase where cation transport proteins are phosphorylated by ATP. These include Na+/K+ ATPases and H+ ATPases, and are inhibited by vandium ions since they resemble phosphate

A

P-type ATPases

27
Q

Type of ATPase that transports Ca++ ions

A

Sarcoplasmic/Endoplasmic c-Reticulum Calcium ATPase

(SERCA) pump

28
Q

What class of molecules inhibit Na+/K+ ATPase

A

Cardiac glycosides (digoxin an digitoxin)

29
Q

What happens when cardiac glycosides such as digoxin and digitoxin inhibit Na+/K+ ATPase in patients with heart failure?

A

It increases intracellular Ca++ levels, which leads to increased stroke volume by making the heart work (contract) harder

30
Q

ATPase that acidifies intracellular compartments in organisms that are between pH 3 and 6.

A

V-Type ATPases

31
Q

ATPase that catalyzes uphill proton movement. They are energy coupling ATPases with the ATP synthase of the mitochondria being the best example

A

F-Type ATPases

32
Q

Transporters that pump a variety of chemicals outside of the cell, such as proteins, amino acids, bile salts, metals, lipids, and sterols

A

ABC transporters

33
Q

What was the first cloned ABC protein

A

Gene for MDR1/p glycoprotein which gave colchicine resistant hamsters, resistance to structurally unrelated drugs… hence MDR1 = Multi-drug-resistant 1

34
Q

What is the role of MDR1/P glycoprotein? (historically)

A

Pump xenobiotics out of healthy cells

35
Q

Where are MDR1/P glycoproteins present in the body?

A

Brain, placenta, testis, retina

36
Q

What makes P glycoprotein special (specifically the evolution of the gene)

A

Protects CNS of adults and infants from a variety of structurally diverse chemicals (promiscuous substrate)

37
Q

P glycoprotein is displays _________ transport.

A

Active transport

38
Q

P glycoprotein issue in cancer patients

A

P glycoprotein can become OVEREXPRESSED in cancer cells after exposure to chemotherapeutic agents, which means it pumps out anticancer drugs so they can’t accumulate inside the cell. This necessitates the use of different drug treatments to overcome resistance